Floridian Research Institute

Miami, Florida 33179-2537

2 studies enrolling now · 12 studies all time

What they study most

Acne Inversa, Acne Vulgaris, Atopic Dermatitis, COVID-19 Prevention, Constipation, Eczema, Focal Epilepsy, Hidradenitis Suppurativa, Hidradenitis Suppurativa (HS), RSV Infection, Suppurative Hidradenitis

Studies at this site

• A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa — Recruiting now
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy — Recruiting now
• A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa — Running, not enrolling
• Long-term Safety and Tolerability of BHV-7000 — Enrolling by invitation
• A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. — Completed
• A Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults — Completed
• A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis — Completed
• A Study to Assess the Efficacy and Safety of the Vibrant Capsule Administered 5 Times Per Week — Completed
• Tolerability, Safety and Efficacy of a New Frequency of Vibrant Capsule Administration — Stopped early
• A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa — Completed
• A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris — Completed
• A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris — Completed